Home Sectors Healthcare Stock in the Spotlight: IQVIA (NYSE: IQV)

Stock in the Spotlight: IQVIA (NYSE: IQV)

21
0
SHARE

IQVIA is in the healthcare sector and trades as part of the medical diagnostics and research industry. The company CEO is Ari Bousbib. IQVIA Inc is an information and technology-enabled healthcare service provider to the pharmaceutical services, biotechnology, and healthcare industries. The Commercial Solutions and Research and Development Solutions generate maximum revenue.

Previous Intraday Trading Performance:

The IQV stock showed a previous change of -0.65% with an open at 128.65 and a close of 128.81. It reached an intraday high of 129.22 and a low of 128.23.

Business Wire:  IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry

Liquidity:

The stock has a market cap of $25.5b with 198.0m shares outstanding, of which the float is 187.4m shares. Trading volume reached 935,367 shares compared to its average volume of 1,158,890 shares. Based on the current average volume and close price, the trading liquidity is good.

Historical Trading Performance:

Over the last five trading days, IQVIA shares returned -0.16% and in the past 30 trading days it returned 14.62%. Over three months, it changed 6.62%. In one year it has changed 22.00% and within that year its 52-week high was 139.65 and its 52-week low was 91.57. IQV stock is 40.67% above its 52 Week Low.

Our calculations show a 200 day moving average of 116.31 and a 50 day moving average of 121.49. Currently IQV stock is trading 10.75% above its 200 day moving average.

Business Wire:  IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry

Earnings:

The last annual fiscal EPS for the company was reported at 5.88 that ended on 31st of December 2017, which according to the previous close, that is a PE of 21.91. Based on 10 analyst estimates, the consensus EPS for the next quarter is 1.36. The TTM EPS is 5.07, which comes to a TTM PE of 25.41. Historically, the PE high was 145.60 and the PE low was 17.90. If the stock reached its PE low, that would represent a price of 90.74, which is a decrease of -29.56%.

The following are the last four quarter reported earnings per share:
09-30-2018:  1.32
06-30-2018:  1.19
03-31-2018:  1.24
12-31-2017:  1.32

Base on our calculations, the intrinsic value per share is 81.99, which means it may be overvalued by -57.11%

Indicators to Watch:

Based on the latest filings, there is 5.10% of insider ownership and 120.50% of institutional ownership. Short-interest is 3,499,679, which is 1.77% of shares outstanding. The short-interest ratio or days-to-cover ratio is 2.40. This stock has some short interest, but it may be normal and no cause for concern if long the position.

The current calculated beta is 0.83

PR Newswire:  Invesco Closed-End Funds Declare Dividends

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 17.25%, return on assets is 5.56%, profit margin is 2.69%, price-to-sales is 3.32 and price-to-book is 3.54.

Company Scores:

All scores are out of six:
 2  :Valuation Score
 4  :Past Performance Score
 2  :Financial Strength Score
 2  :Future Growth Score
 0  :Dividend Score
 2  :Overall Score

SHARE
John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.

LEAVE A REPLY

Please enter your comment!
Please enter your name here